File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: N-Acetylcysterine and Allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α /HO-1 signaling in diabetic rats

TitleN-Acetylcysterine and Allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α /HO-1 signaling in diabetic rats
Authors
Issue Date2013
PublisherOMICS publishing group. The Journal's web site is located at http://www.omicsonline.org/jdmhome.php
Citation
The 4th World Congress on Diabetes & Metabolism, Chicago, Illinois, USA, 14-16 August 2013. In Journal of Diabetes & Metabolism, 2013, v. 4 n. 6, p. 90 How to Cite?
AbstractBackground: The antioxidants N-acetylcysteine (NAC) and allopurinol (ALP) can synergistically reduce myocardial ischemia/ reperfusion (MI/R) injury in rats with streptozotocin (STZ) - induced diabetes. We investigated whether or not NAC and ALP confer synergistic cardioprotection by stabilizing hypoxia inducible factor 1-α (HIF-1α)/hemeoxygenase 1 (HO-1) signaling in the diabetic myocardium. Methods: Control or diabetic Sprague-Dawleyrats received vehicle, NAC, ALP or their combination for four weeks starting one week after STZ injection. The animals were then subjected to 30 minutes of coronary artery occlusion followed by two hours of reperfusion in the absence or presence of tin protoporphyrin-IX (selective HO-1 inhibitor) or 2-Methoxyestradiol (HIF-1α inhibitor). Cardiomyocytes exposed to high glucose were subjected to hypoxia/re-oxygenation in the absence or presence of HIF- 1α siRNA or HO-1 siRNA. Results: Myocardial and plasma levels of 15-F2t-isoprostane, an index of oxidative stress, were increased significantly in diabetic rats while cardiac HO-1 protein and activity were reduced, which was accompanied with decreased cardiac protein levels of HIF-1α and augmented post-ischemic myocardial infarct size and cellular injury. Both NAC and ALP but in particular their combination normalized cardiac levels of HO-1 and HIF-1α protein expression and prevented the increase in 15-F2t-isoprostane, resulting in significantly attenuated post-ischemic myocardial infarction. NAC and ALP also attenuated hyperglycemia-induced post-hypoxic cardiomyocyte death in vitro. However, pharmacological inhibition of HIF-1α or HO-1 or their gene knock-down prevented the protective effects of NAC and ALP. Conclusion: NAC and ALP confer pharmacological cardioprotection in diabetes via the restoration of cardiac HIF-1α and HO-1.
Persistent Identifierhttp://hdl.handle.net/10722/190358
ISSN

 

DC FieldValueLanguage
dc.contributor.authorXia, Zen_US
dc.date.accessioned2013-09-17T15:20:19Z-
dc.date.available2013-09-17T15:20:19Z-
dc.date.issued2013en_US
dc.identifier.citationThe 4th World Congress on Diabetes & Metabolism, Chicago, Illinois, USA, 14-16 August 2013. In Journal of Diabetes & Metabolism, 2013, v. 4 n. 6, p. 90en_US
dc.identifier.issn2155-6156-
dc.identifier.urihttp://hdl.handle.net/10722/190358-
dc.description.abstractBackground: The antioxidants N-acetylcysteine (NAC) and allopurinol (ALP) can synergistically reduce myocardial ischemia/ reperfusion (MI/R) injury in rats with streptozotocin (STZ) - induced diabetes. We investigated whether or not NAC and ALP confer synergistic cardioprotection by stabilizing hypoxia inducible factor 1-α (HIF-1α)/hemeoxygenase 1 (HO-1) signaling in the diabetic myocardium. Methods: Control or diabetic Sprague-Dawleyrats received vehicle, NAC, ALP or their combination for four weeks starting one week after STZ injection. The animals were then subjected to 30 minutes of coronary artery occlusion followed by two hours of reperfusion in the absence or presence of tin protoporphyrin-IX (selective HO-1 inhibitor) or 2-Methoxyestradiol (HIF-1α inhibitor). Cardiomyocytes exposed to high glucose were subjected to hypoxia/re-oxygenation in the absence or presence of HIF- 1α siRNA or HO-1 siRNA. Results: Myocardial and plasma levels of 15-F2t-isoprostane, an index of oxidative stress, were increased significantly in diabetic rats while cardiac HO-1 protein and activity were reduced, which was accompanied with decreased cardiac protein levels of HIF-1α and augmented post-ischemic myocardial infarct size and cellular injury. Both NAC and ALP but in particular their combination normalized cardiac levels of HO-1 and HIF-1α protein expression and prevented the increase in 15-F2t-isoprostane, resulting in significantly attenuated post-ischemic myocardial infarction. NAC and ALP also attenuated hyperglycemia-induced post-hypoxic cardiomyocyte death in vitro. However, pharmacological inhibition of HIF-1α or HO-1 or their gene knock-down prevented the protective effects of NAC and ALP. Conclusion: NAC and ALP confer pharmacological cardioprotection in diabetes via the restoration of cardiac HIF-1α and HO-1.-
dc.languageengen_US
dc.publisherOMICS publishing group. The Journal's web site is located at http://www.omicsonline.org/jdmhome.php-
dc.relation.ispartofJournal of Diabetes & Metabolismen_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleN-Acetylcysterine and Allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α /HO-1 signaling in diabetic ratsen_US
dc.typeConference_Paperen_US
dc.identifier.emailXia, Z: zyxia@hkucc.hku.hken_US
dc.identifier.authorityXia, Z=rp00532en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.4172/2155-6156.S1.022-
dc.identifier.hkuros221934en_US
dc.identifier.volume4en_US
dc.identifier.issue6en_US
dc.identifier.spage90en_US
dc.identifier.epage90en_US
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats